Team:UFAM Brazil/7-5-2014

From 2014.igem.org

(Difference between revisions)
 
(3 intermediate revisions not shown)
Line 11: Line 11:
<tr><td colspan="3"><p>
<tr><td colspan="3"><p>
-
Results with the antibiotics tests:
+
Results of the antibiotics tests:
</p></td></tr>
</p></td></tr>
Line 17: Line 17:
<tr>
<tr>
-
<td colspan="3" align="center">
+
<td colspan="1" align="center">
<img src="https://static.igem.org/mediawiki/2014/6/6a/UFAM_Brazil_2014_7-5-2014.jpg" width="400" heigth="500" >
<img src="https://static.igem.org/mediawiki/2014/6/6a/UFAM_Brazil_2014_7-5-2014.jpg" width="400" heigth="500" >
 +
</td>
</td>
-
<td>
+
<td colspan="1" align="center">
-
<p><b>Legend</b></p><p style="background-color:green">Green: it grew.</p>
+
<p><b>Legend</b></p>
 +
<p style="background-color:green ">Green: it grew.</p>
<p style="background-color:yellow">Yellow: It didn’t grow at a good amount</p>
<p style="background-color:yellow">Yellow: It didn’t grow at a good amount</p>
-
<p style="background-color:red">Red: It didn’t grow</p></td>
+
<p style="background-color:red">Red: It didn’t grow</p>
 +
</td>
 +
 
</tr>
</tr>
-
<tr><td  colspan="10" height="50"></td></tr>
 
-
<tr><td  colspan="3" align="center"><p> Pictures of our trials using antibiotic in the JM110 e ERC2925 E.coli lines
+
 
 +
<tr><td  colspan="3" align="center"><p> Pictures of our trials using antibiotic on JM110 and ERC2925 <i>E. coli</i>
ER5C2925 – Trial with Streptomycin, in order: <i>20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml</i>:
ER5C2925 – Trial with Streptomycin, in order: <i>20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml</i>:
</p>
</p>
Line 38: Line 42:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with Ampicillin: <i>50ug/ml and100ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with Ampicillin: <i>50ug/ml and 100ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 45: Line 49:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with Tetracycline :<i> 12 ug/ml and 24 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with Tetracycline:<i> 12 ug/ml and 24 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 52: Line 56:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with Kanamycin: <i>25 ug/ml e 50 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with Kanamycin: <i>25 ug/ml and 50 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 59: Line 63:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with <i>Chloramphenicol: 34 ug/ml and 68 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p> ER5C2925 – Trials with Chloramphenicol: <i>34 ug/ml and 68 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 66: Line 70:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p>JM110 – Trials with <i>Streptomycin: 20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p>JM110 – Trials with Streptomycin: <i>20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 73: Line 77:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p>JM110 – Trials with<i> Tetraciclyn:12 ug/ml e 24 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p>JM110 – Trials with Tetraciclyn: <i>12 ug/ml and 24 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 80: Line 84:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p>JM110 – Trial with <i>Ampicylin 50 ug/ml 100 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p>JM110 – Trial with Ampicylin <i>50 ug/ml and 100 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 87: Line 91:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p>JM110 – Trial with <i>Kanamycin: 25 ug/ml and 50 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p>JM110 – Trial with Kanamycin: <i>25 ug/ml and 50 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 94: Line 98:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" align="center"><p>JM110 – Trials with <i>chloramphenicol: 34 ug/ml and 68 ug/ml</i>:</p>
+
<tr><td  colspan="3" align="center"><p>JM110 – Trials with chloramphenicol: <i>34 ug/ml and 68 ug/ml</i>:</p>
</td></tr>
</td></tr>
Line 101: Line 105:
</td></tr>
</td></tr>
-
<tr><td  colspan="3" ><p>Today we also cryopreserved the bacteria with glycerol and we inoculated LB soft medium to store them.</p>
+
<tr><td  colspan="3" ><p>Today we also cryopreserved the bacteria with glycerol and was inoculated in LB soft medium to store them.</p>
-
<p> We transformed using the Transformation Protocol using Sorbitol in the li <i>E. coli</i> JM110 e ERC2925 lines with the pUC72 plasmid. </p>
+
<p> We transformed using the Transformation Protocol, using Sorbitol on <i>E. coli</i> JM110 and ERC2925 with the pUC72 plasmid. </p>
</td></tr>
</td></tr>

Latest revision as of 23:01, 16 October 2014

07/05/2014

Results of the antibiotics tests:

Legend

Green: it grew.

Yellow: It didn’t grow at a good amount

Red: It didn’t grow

Pictures of our trials using antibiotic on JM110 and ERC2925 E. coli ER5C2925 – Trial with Streptomycin, in order: 20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml:

ER5C2925 – Trials with Ampicillin: 50ug/ml and 100ug/ml:

ER5C2925 – Trials with Tetracycline: 12 ug/ml and 24 ug/ml:

ER5C2925 – Trials with Kanamycin: 25 ug/ml and 50 ug/ml:

ER5C2925 – Trials with Chloramphenicol: 34 ug/ml and 68 ug/ml:

JM110 – Trials with Streptomycin: 20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml:

JM110 – Trials with Tetraciclyn: 12 ug/ml and 24 ug/ml:

JM110 – Trial with Ampicylin 50 ug/ml and 100 ug/ml:

JM110 – Trial with Kanamycin: 25 ug/ml and 50 ug/ml:

JM110 – Trials with chloramphenicol: 34 ug/ml and 68 ug/ml:

Today we also cryopreserved the bacteria with glycerol and was inoculated in LB soft medium to store them.

We transformed using the Transformation Protocol, using Sorbitol on E. coli JM110 and ERC2925 with the pUC72 plasmid.

Back Next

Retrieved from "http://2014.igem.org/Team:UFAM_Brazil/7-5-2014"